Organon & Co Shares Are Trading Lower After the FDA Extended the Target Action Date of Its Review for the Company's Supplemental New Drug Application for Vtama Cream.
Organon & Co Shares Are Trading Lower After the FDA Extended the Target Action Date of Its Review for the Company's Supplemental New Drug Application for Vtama Cream.
Organon & Co股價下跌，因爲FDA將其對Vtama Cream補充新藥申請的審查目標日期延長。
Organon & Co Shares Are Trading Lower After the FDA Extended the Target Action Date of Its Review for the Company's Supplemental New Drug Application for Vtama Cream.
Organon & Co股價下跌，因爲FDA延長了對該公司Vtama Cream補充新藥申請的審查目標行動日期。
資訊熱榜
更新時間